Impact of Concurrent STK11 Loss and c-MYC Amplification in Metastatic Non-Small Cell Lung Cancer (NSCLC)

被引：0

作者：

Menon, S. ^{[1
]}

Ellis, C. ^{[2
]}

Poudel, S. ^{[3
]}

Johnson, J. ^{[1
,4
]}

Szabo, A. ^{[1
]}

George, B.

Kelly, W. Kevin ^{[4
]}

Grant, S. ^{[5
]}

McPherson, J. ^{[6
]}

Cristofanilli, M. ^{[7
]}

Hoimes, C. ^{[8
]}

Gutierrez, M. ^{[9
]}

Doudement, J. ^{[10
]}

Chan, L. ^{[10
]}

Singal, G. ^{[10
]}

Alexander, B. ^{[10
]}

Miller, V. ^{[10
]}

Sohal, D. ^{[11
]}

机构：

[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[2] Univ N Carolina, Chapel Hill, NC USA

[3] Cleveland Clin, Cleveland, OH 44106 USA

[4] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[5] Wake Forest, Winston Salem, NC USA

[6] Univ Calif Davis, Sacramento, CA USA

[7] Northwestern Univ, Chicago, IL 60611 USA

[8] Seidman Univ Hosp, Cleveland, OH USA

[9] Reg Canc Care Associates, Hackensack, NJ USA

[10] Fdn Med, Boston, MA USA

[11] Univ Cincinnati, Cincinnati, OH USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B08

引用

页码：S29 / S30

页数：2

共 50 条

[1] Amplification of the c-myc oncogene in non-small cell lung cancer
Özkara, HA
Özkara, S
Topçu, S
Criss, WE
[J]. TUMORI JOURNAL, 1999, 85 (06): : 508 - 511
[2] STK11 mutations in non-small cell lung cancer (NSCLC): descriptive analysis and prognostic significance
Facchinetti, Francesco
Bluthgen, Maria Virginia
Clain, Gabrielle Tergemina
Faivre, Laura
Pignon, Jean-Pierre
Planchard, David
Soria, Jean-Charles
Besse, Benjamin
Lacroix, Ludovic
[J]. CANCER RESEARCH, 2016, 76
[3] Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
An, Josiah
Yan, Melissa
Yu, Nanmeng
Chennamadhavuni, Adithya
Furqan, Muhammad
Mott, Sarah L.
Loeffler, Bradley T.
Kruser, Timothy
Sita, Timothy L.
Feldman, Lawrence
Nguyen, Ryan
Pasquinelli, Mary
Hanna, Nasser H.
Abu Hejleh, Taher
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (08) : 3608 - 3615
[4] Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
Rosellini, Pietro
Amintas, Samuel
Caumont, Charline
Veillon, Remi
Galland-Girodet, Sigolene
Cuguilliere, Alain
Nguyen, Laurent
Domblides, Charlotte
Gouverneur, Amandine
Merlio, Jean-Philippe
Bezin, Julien
Girodet, Pierre-Olivier
[J]. EUROPEAN JOURNAL OF CANCER, 2022, 172 : 85 - 95
[5] Role of STK11 in ALK-positive non-small cell lung cancer
Zhou, Wen
Yan, Lu-Da
Yu, Zhi-Qiong
Li, Na
Yang, Yong-Hua
Wang, Meng
Chen, Yuan-Yuan
Mao, Meng-Xia
Peng, Xiao-Chun
Cai, Jun
[J]. ONCOLOGY LETTERS, 2022, 23 (06)
[6] Mutations of the LKB1/STK11 gene in non-small cell lung cancer with loss of heterozygosity
Yang, Sei-Hoon
Meerzaman, Daoud
Mechanic, Leah E.
Gill, Rajbir
Dracheva, Tatiana
Han, Seung-Bum
Kim, Sam-Yong
Bowman, Elise D.
Harris, Curtis C.
Jen, Jin
[J]. ANNALS OF ONCOLOGY, 2006, 17 : 246 - 246
[7] Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
An, Josiah
Yan, Melissa
Yu, Nanmeng
Chennamadhavuni, Adithya
Furqan, Muhammad
Kruser, Timothy
Sita, Timothy L.
Nguyen, Ryan
Feldman, Lawrence Eric
Pasquinelli, Mary
Hanna, Nasser H.
Abu Hejleh, Taher
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[8] Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
Sumbly, Vikram
Landry, Ian
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
[9] Impact of STK11 and KRAS co-mutations on outcomes with immunotherapy in non-small cell lung cancer.
Basher, Fahmin
Saravia, Diana
Fanfan, Dino
Cotta, Jared Addison
Lopes, Gilberto
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[10] Impact of STK11 copy loss on clinical outcomes to PD-(L)1 blockade in non-small cell lung cancer.
Gutierrez, Catherine
Ricciuti, Biagio
Alessi, Joao Victor Machado
Pecci, Federica
De Castro Barrichello, Adriana Paula
Vaz, Victor R.
Sholl, Lynette M.
Awad, Mark M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →